A detailed history of J. Goldman & CO LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, J. Goldman & CO LP holds 13,500 shares of TEVA stock, worth $230,985. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,500
Previous 27,000 50.0%
Holding current value
$230,985
Previous $380,000 42.37%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $172,530 - $234,899
-13,500 Reduced 50.0%
13,500 $219,000
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $5.35 Million - $7.66 Million
-715,500 Reduced 96.36%
27,000 $275,000
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $5.35 Million - $7.03 Million
742,500 New
742,500 $5.59 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.